Autolus Therapeutics plc (AUTL) › Net IncomeAutolus Therapeutics plc (AUTL) — Net IncomeAnnual figures by fiscal year, from SEC filings.2016: -$12.55M2017: -$19.73M2018: -$44.75M2019: -$123.85M2020: -$142.09M2021: -$142.10M2022: -$148.84M2023: -$208.38M2024: -$220.66M2025: -$287.53M-$287.53M2016Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$287.53M-30.3%2024-$220.66M-5.9%2023-$208.38M-40.0%2022-$148.84M-4.7%2021-$142.10M-0.0%2020-$142.09M-14.7%2019-$123.85M-176.8%2018-$44.75M-126.9%2017-$19.73M-57.2%2016-$12.55M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share